Microba Life Sciences, a precision microbiome science company, will showcase its Therapeutic Platform and Discovery Platform for the identific...
We are innovating to help humanity achieve some of its most inspiring medical advancements in the 21st century. Read about Microba’s progress, partnership news and latest discoveries.
Microba receives ISO15189 accreditation for untargeted metagenomic assay of stool samples, unlocking diagnostic applications of the microbiome.
Precise measurement of the gut microbiome empowers new discoveries in research and the development of innovative treatments and diagnostics.
Published study found a method designed for preserving forensic DNA outperformed other commonly used faecal preservation methods.
Microba Community Profiler (MCP) outperforms existing profilers for accurate and comprehensive characterisation of the human gut microbiome.
Microba Life Sciences, is empowering global consumer goods company Unilever to explore links between sleep and the human gut.
Microba’s commitment to developing life-changing therapeutics derived from the gut microbiome will add a valuable voice to MTIG’s mission.
The partnership's first clinical trial will determine if a new treatment can restore beneficial gut microbiome species and improve symptoms.
Bringing Microba’s world-leading metagenomic sequencing and bioinformatics together with Holobiome’s promising microbiome therapeutic pipeline.